A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitro

European Journal of Immunology
A S WhiteheadW F Bodmer

Abstract

A monoclonal antibody (WM1) against the third component of human complement (C3) was produced by fusing P3-X63-Ag8 mouse myeloma cells with spleen cells from BALB/c mice immunized with purified C3. The specificity of WM1 antibody against C3 was established by its capacity to inhibit a standard C3 hemolytic assay and to immunoprecipitate C3 from human serum in the presence of S. aureus bacteria. Indirect binding assays indicate that the antibody is directed the C3c portion of C3. The immunoprecipitation technique was used to screen for the presence of C3 in the culture supernatants of various cell lines. By this means, C3 was identified as a secreted product of human primary fibroblasts, transformed fibroblasts and D98/AH-2, a HeLa derivative, but not of other human cell lines. WM1 was unable to immunoprecipitate C3 from rabbit or mouse fibroblast culture supernatants.

References

Jan 1, 1979·Immunological Reviews·F M BrodskyW F Bodmer
Feb 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·F P Da SilvaP Rubinstein
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·F J Benham, H Harris
Sep 1, 1978·British Medical Bulletin·P J Lachmann, M J Hobart
Jan 1, 1979·Advances in Protein Chemistry·R R Porter, K B Reid
Nov 1, 1977·The Journal of Experimental Medicine·P P Jones
Sep 1, 1977·The Journal of Experimental Medicine·V BradeH R Colten
Dec 1, 1977·The Biochemical Journal·K B Reid, E Solomon
Jul 26, 1969·Nature·M NabholzW Bodmer
Apr 1, 1970·The Journal of Cell Biology·R J KlebeF H Ruddle
Dec 1, 1964·Proceedings of the Society for Experimental Biology and Medicine·A P DALMASSO, H J MUELLER-EBERHARD

❮ Previous
Next ❯

Citations

May 1, 1982·Somatic Cell Genetics·J E Brissenden, D W Cox
Dec 1, 1981·In Vitro·R H Kennett
May 11, 2013·Cancer Gene Therapy·D MaggeD L Bartlett
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·A S WhiteheadG Fey
Oct 1, 1985·The Journal of Clinical Investigation·D H PerlmutterD D Chaplin
Jan 1, 1993·International Reviews of Immunology·M Botto, M J Walport
Mar 1, 1986·Scandinavian Journal of Immunology·B Nilsson, U R Nilsson
Jan 1, 1989·Scandinavian Journal of Immunology·G HetlandE Johnson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.